Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15673801 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Condition: Wegener's Granulomatosis
Intervention: Drug: Abatacept
2 Active, not recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine

Study has passed its completion date and status has not been verified in more than two years.